ArTS Archivio della ricerca di Trieste

BULLA, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.179
EU - Europa 7.897
AS - Asia 6.532
SA - Sud America 805
AF - Africa 219
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 11
AN - Antartide 1
Totale 28.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.960
SG - Singapore 2.497
PL - Polonia 1.496
IT - Italia 1.420
CN - Cina 1.365
DE - Germania 980
SE - Svezia 874
VN - Vietnam 700
BR - Brasile 612
HK - Hong Kong 601
RU - Federazione Russa 548
UA - Ucraina 542
GB - Regno Unito 487
FR - Francia 382
KR - Corea 382
FI - Finlandia 291
NL - Olanda 213
TR - Turchia 193
IE - Irlanda 168
IN - India 166
BG - Bulgaria 130
CA - Canada 116
JP - Giappone 89
MA - Marocco 71
AR - Argentina 64
TW - Taiwan 64
MX - Messico 59
BD - Bangladesh 54
BE - Belgio 54
ID - Indonesia 53
CH - Svizzera 51
ZA - Sudafrica 48
AT - Austria 47
IQ - Iraq 43
ES - Italia 38
IR - Iran 33
AE - Emirati Arabi Uniti 32
SA - Arabia Saudita 31
PH - Filippine 30
PK - Pakistan 30
EC - Ecuador 28
CZ - Repubblica Ceca 26
AU - Australia 25
VE - Venezuela 25
CL - Cile 24
PT - Portogallo 22
SN - Senegal 22
UZ - Uzbekistan 22
EG - Egitto 21
IL - Israele 20
TH - Thailandia 19
MY - Malesia 18
RO - Romania 18
CO - Colombia 16
HU - Ungheria 16
AZ - Azerbaigian 15
LT - Lituania 15
DK - Danimarca 13
PY - Paraguay 13
PE - Perù 12
DZ - Algeria 10
GR - Grecia 10
TN - Tunisia 10
JO - Giordania 9
NG - Nigeria 9
OM - Oman 9
SI - Slovenia 9
TT - Trinidad e Tobago 9
EU - Europa 8
MD - Moldavia 8
PA - Panama 8
GE - Georgia 7
KE - Kenya 7
LB - Libano 7
NP - Nepal 7
CR - Costa Rica 6
EE - Estonia 6
HN - Honduras 6
HR - Croazia 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
RS - Serbia 6
BO - Bolivia 5
CI - Costa d'Avorio 5
ET - Etiopia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NO - Norvegia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
KW - Kuwait 4
AM - Armenia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
Totale 28.641
Salva come PNG Salva come JPEG
Città #
Singapore 1.514
Ashburn 1.347
Warsaw 1.345
Fairfield 1.266
Woodbridge 1.081
Ann Arbor 882
Houston 769
Chandler 735
San Jose 676
Hong Kong 563
Wilmington 545
Seattle 514
Dallas 509
Trieste 485
Jacksonville 440
Cambridge 423
Seoul 369
Beijing 327
Hefei 293
Boardman 243
Princeton 227
Ho Chi Minh City 197
Los Angeles 181
Chicago 177
Columbus 151
Hanoi 145
Dublin 144
Moscow 133
The Dalles 133
Izmir 132
Sofia 128
Lauterbourg 123
Zgierz 115
Santa Clara 113
Helsinki 107
London 99
New York 97
Frankfurt am Main 96
Council Bluffs 88
Buffalo 87
Munich 80
Dearborn 71
San Diego 69
São Paulo 60
Taipei 58
Shanghai 56
Casablanca 53
Milan 52
Tokyo 51
Dong Ket 49
Falls Church 49
North Bergen 44
Bern 43
Düsseldorf 42
Brussels 40
Da Nang 38
Des Moines 33
Orem 33
Turku 33
Atlanta 32
Guangzhou 31
Menlo Park 31
Redmond 31
Redondo Beach 31
Toronto 31
Amsterdam 30
Montreal 30
Stockholm 30
Washington 30
Nuremberg 29
Redwood City 29
Vienna 27
Phoenix 26
Saint Petersburg 26
Chennai 25
Nanjing 25
Haiphong 24
San Francisco 24
Venice 24
Denver 23
Fort Wayne 23
Jakarta 23
Jinan 23
Dakar 22
Johannesburg 22
Lappeenranta 22
Boston 21
Kyiv 21
Poplar 21
Rome 21
Arzene 20
Baghdad 20
Treviso 20
Brooklyn 19
Rio de Janeiro 19
Tashkent 18
Belo Horizonte 17
Duino-Aurisina 17
Boydton 16
Bremen 16
Totale 18.943
Salva come PNG Salva come JPEG
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 856
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 504
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 483
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 407
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 395
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1 363
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 350
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 336
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 332
Pathological significance and prognostic value of surfactant protein D in cancer 304
Pre-eclampsia affects procalcitonin production in placental tissue 302
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 302
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 301
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 299
Analysis of anti-C1q antibodies in normal and pathological pregnancies 299
C1q is involved in human trophoblast invasion 297
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 287
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 286
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 283
C1q is associated with a reduced inflammatory response of decidual endothelial cells 281
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 271
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 269
null 263
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 257
C1q: A novel angiogenic factor? 253
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 251
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 249
Alternative functions of the complement protein C1q at embryo implantation site 248
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 248
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 247
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 245
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 244
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 242
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 238
Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules 237
Placental trophoblast and endothelial cells as target of maternal immune response. 236
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 226
An insight into normal and pathological pregnancies using large-scale microarrays: lessons from microarrays. 223
The role of complement component C1q in angiogenesis 220
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP 218
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 217
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 213
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 208
Preeclampsia is associated with defective production of C1q by invasive trophoblast 200
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 198
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 195
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 195
The terminal complement complex induces vascular leakage: in vitro and in vivo evidence 192
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 191
THE CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCES OF C1Q EXPRESSION IN GLIOMAS: A BIOINFORMATICS ANALYSIS 190
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 189
Overview of procalcitonin in pregnancy and in pre-eclampsia 189
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 188
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 188
Emerging Roles of the Complement System at Foeto-maternal Interface 186
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients 184
The complement system at the embryo implantation site 183
Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina 179
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 177
Surfactant protein D in immune surveillance against cancer 177
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 175
Prevalence and biological effects of anti-trophoblast and anti-endothelial cell antibodies in patients with recurrent spontaneous abortions. 175
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 172
[The maternal-fetal immune relationship in pregnancy] 172
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex. 172
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 170
The Complement System at the Embryo Implantation Site: Friend or Foe? 170
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating 169
Human eosinophil peroxidase enhances tumor necrosis factor and hydrogen peroxide release by human monocyte-derived macrophages 169
Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering 169
Prognostic Implications of the Complement Protein C1q in Gliomas 166
C1q as pro-angiogenic factor in the context of ovarian tissue transplantation 165
Analysis of the molecular mechanisms of C1-inhibitor deficiency induced angioedema 164
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 162
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 162
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 162
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels 161
null 161
Complement activation in animal and human pregnancies as a model for immunological recognition 159
null 159
”Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflamation”F.Fischetti, R. Carretta, G. Borotto, P. Durigutto, R. Bulla, P.L. Meroni, F. Tedesco. 157
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 156
A non-redundant role of complement protein C1q in normal and adverse pregnancy 155
null 155
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 155
Proangiogenic properties of complement protein C1q can contribute to endometriosis 154
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 154
null 154
At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success 154
VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. 153
null 151
Effect of a standardized liver and spleen fraction of peptides on the differentiation of human monocyte derived macrophages. 151
COVID-19, Pre-Eclampsia, and Complement System 151
Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions 150
C1q induces in vivo angiogenesis and promotes wound healing 148
Study of the prognostic significance of the protein C1q in carcinomas 147
Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. 146
The mannose binding lectin pathway and early complement activation in (murine) abortion 143
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 142
Pathophysiology of the Complement System at Feto-Maternal Interface 142
Totale 22.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021543 0 0 0 0 0 0 0 0 0 255 96 192
2021/20221.910 66 119 138 123 77 174 113 86 241 191 136 446
2022/20232.420 232 326 178 350 218 405 32 211 275 34 109 50
2023/20241.832 148 100 154 119 158 203 307 265 58 75 136 109
2024/20253.662 81 126 283 263 331 349 250 206 511 456 371 435
2025/20268.701 974 618 772 935 817 827 1.440 282 988 1.048 0 0
Totale 29.372